| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±2.2% | -2.6% | under-priced |
| October 30, 2025 | ±3.0% | -0.1% | over-priced |
| August 7, 2025 | ±1.4% | +0.4% | over-priced |
| May 8, 2025 | ±1.6% | -0.4% | over-priced |
| October 31, 2024 | ±2.4% | -2.7% | under-priced |
| August 2, 2024 | ±4.2% | -1.3% | over-priced |
| May 2, 2024 | ±1.9% | +0.8% | over-priced |
| November 2, 2023 | ±2.4% | +2.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.52 | $4.1B | $437M |
| Q4 FY2025 | $1.98 | $4.2B | $569M |
| Q3 FY2025 | $2.05 | $4.2B | $590M |
| Q2 FY2025 | $1.84 | $4.0B | $529M |
Ecolab, Inc. (ECL) reports in 101 days, with the next report estimated for September 22, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced ECL's earnings risk. Fundamentals into the print: EPS up 7.8% year-over-year, revenue up 10.0%. QuantLogix's live 5-factor engine currently reads ECL as a buy at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →